Bavencio

Made by

• Merck Biopharma

Active Ingredient

Avelumab (genetical recombination)

Prospectus

Approval date

2017/9/27

Treats

• Merkel cell carcinoma
• Renal cell carcinoma
• Bladder cancer

Dosages

• BAVENCIO intravenous infusion - 196289円／瓶